Variant report
Variant | nsv525207 |
---|---|
Chromosome Location | chr8:20685467-20691295 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10103263 | chr8:20685467-20685468 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574005350 | chr8:20685492-20685493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs137859233 | chr8:20685522-20685523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143406416 | chr8:20685534-20685535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190637899 | chr8:20685551-20685552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545590952 | chr8:20685572-20685573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2616162 | chr8:20685586-20685587 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs147151876 | chr8:20685588-20685589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549931187 | chr8:20685592-20685593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370261638 | chr8:20685615-20685616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567961802 | chr8:20685627-20685628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183272295 | chr8:20685639-20685640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567753569 | chr8:20685663-20685664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547090111 | chr8:20685796-20685797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138931044 | chr8:20685852-20685853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79625442 | chr8:20685853-20685854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17494497 | chr8:20685856-20685857 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs149440100 | chr8:20685866-20685867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537124776 | chr8:20685932-20685933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553698008 | chr8:20685942-20685943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562870697 | chr8:20686004-20686005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573942178 | chr8:20686024-20686025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541374541 | chr8:20686042-20686043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200775945 | chr8:20686063-20686064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187574231 | chr8:20686074-20686075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs578170901 | chr8:20686082-20686083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545750725 | chr8:20686175-20686176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563851696 | chr8:20686192-20686193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572263403 | chr8:20686212-20686213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531178799 | chr8:20686217-20686218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144767905 | chr8:20686301-20686302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74393274 | chr8:20686309-20686310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75609590 | chr8:20686337-20686338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17093228 | chr8:20686360-20686361 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs75069730 | chr8:20686367-20686368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11985378 | chr8:20686381-20686382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528065046 | chr8:20686392-20686393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551289154 | chr8:20686394-20686395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368504323 | chr8:20686410-20686411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557905669 | chr8:20686438-20686439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2583672 | chr8:20686480-20686481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs543966949 | chr8:20686501-20686502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548914558 | chr8:20686513-20686514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567704716 | chr8:20686542-20686543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78127045 | chr8:20686554-20686555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553316814 | chr8:20686582-20686583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs17093229 | chr8:20686596-20686597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539336354 | chr8:20686612-20686613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73668222 | chr8:20686632-20686633 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs190703809 | chr8:20686638-20686639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20684400-20689800 | Weak transcription | Fetal Heart | heart |
2 | chr8:20689400-20689600 | Enhancers | Placenta | Placenta |
3 | chr8:20689400-20690200 | Enhancers | Ovary | ovary |
4 | chr8:20689400-20690600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr8:20689400-20690600 | Enhancers | Liver | Liver |
6 | chr8:20689400-20690600 | Enhancers | Fetal Lung | lung |
7 | chr8:20689400-20690800 | Enhancers | Fetal Stomach | stomach |
8 | chr8:20689400-20691000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr8:20689600-20690800 | Weak transcription | Placenta | Placenta |
10 | chr8:20689800-20690200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr8:20689800-20690200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr8:20689800-20690200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr8:20689800-20690200 | Enhancers | Fetal Heart | heart |
14 | chr8:20689800-20690400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:20689800-20690400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr8:20689800-20691000 | Enhancers | Fetal Kidney | kidney |
17 | chr8:20690200-20694400 | Weak transcription | Fetal Heart | heart |
18 | chr8:20690600-20691800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr8:20690800-20691800 | Enhancers | Placenta | Placenta |
20 | chr8:20691000-20691800 | Weak transcription | Fetal Kidney | kidney |